Blueshift Asset Management, LLC Karuna Therapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$176.32 - $240.22 $348,232 - $474,434	1,975 New	1,975 $428,000
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $464,268 - $574,051	2,424 New	2,424 $476,000
Q4 2021 Feb 11, 2022	SELL	$110.64 - $159.4 $331,920 - $478,200	-3,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$101.2 - $125.87 $34,306 - $42,669	-339 Reduced 10.15%	3,000 $367,000
Q2 2021 Aug 13, 2021	BUY	$107.45 - $135.95 $358,775 - $453,937	3,339 New	3,339 $381,000
Q1 2021 May 06, 2021	SELL	$95.46 - $133.08 $395,968 - $552,015	-4,148 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$75.23 - $109.23 $312,054 - $453,086	4,148 New	4,148 $421,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.